Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Stock-Based Compensation, Restricted Stock and Stock Options [Abstract]  
Schedule of Activity Under the Plans A summary of activity under the Plans for the nine months ended September 30, 2023 is as follows:
    Shares
Underlying
Options		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term
(Years)		     Aggregate
Intrinsic
Value		  
Outstanding at December 31, 2022     159,295     $ 153.35       6.5     $ 26,188  
Forfeited     (1,516 )   $ 196.86      
-
       -  
Outstanding at September 30, 2023     157,779     $ 157.47       5.8     $
-
  
                                 
Exercisable at September 30, 2023     143,325     $ 168.04       5.5     $
-
  
Schedule of Stock-Based Compensation Expense Recognized The total stock-based compensation expense recognized was as follows (in thousands):
    Three months ended
September 30,		     Nine months ended
September 30,		  
    2023     2022     2023     2022  
                         
Research and development expenses   $ 46     $ 136     $ 150     $ 636  
Selling, general and administrative expenses     87       344       296       2,375  
Total stock-based compensation   $ 133     $ 480     $ 446     $ 3,011  
Schedule of Restricted Stock Activity A summary of the Company’s restricted stock activity and related information is as follows:
    Number of
Shares		     Weighted
Average
Grant-Date
Fair Value		  
Unvested at December 21, 2022     10,483     $ 82.02  
Vested     (3,344 )   $ 104.04  
Unvested at September 30, 2023     7,139     $ 71.68